XML 24 R8.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings (Accumulated Deficit)
Beginning balance (in shares) at Mar. 31, 2020 76,287,000        
Beginning balance at Mar. 31, 2020 $ 81,458        
Ending balance (in shares) at Mar. 31, 2021 76,287,000        
Ending balance at Mar. 31, 2021 $ 81,458        
Beginning balance (in shares) at Mar. 31, 2020   68,566,000      
Beginning balance at Mar. 31, 2020 1,136 $ 68 $ 14,954 $ 0 $ (13,886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 7,398   7,398    
Exercise of stock options (in shares)   13,890,000      
Exercise of stock options 8,897 $ 14 8,883    
Issuance of common stock in exchange for services (in shares)   22,000      
Issuance of common stock in exchange for services 34   34    
Repurchase and retirement of common stock (in shares)   (258,000)      
Repurchase and retirement of common stock (2,022)   (2,022)    
Common stock warrant expense 49   49    
Issuance of common stock in connection with an acquisition (in shares)   690,000      
Issuance of common stock in connection with an acquisition 1,062 $ 1 1,061    
Other comprehensive income (loss) (21)     (21)  
Net income 50,210       50,210
Ending balance (in shares) at Mar. 31, 2021   82,910,000      
Ending balance at Mar. 31, 2021 $ 66,743 $ 83 30,357 (21) 36,324
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock upon initial public offering (in shares) (76,287,000)        
Conversion of redeemable convertible preferred stock upon initial public offering $ (81,458)        
Ending balance (in shares) at Mar. 31, 2022 0        
Ending balance at Mar. 31, 2022 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 29,341   29,341    
Exercise of stock options (in shares)   10,823,000      
Exercise of stock options 12,612 $ 11 12,601    
Vesting of restricted stock units (in shares)   24,000      
Tax withholding on shares under stock-based compensation awards (817)   (817)    
Repurchase and retirement of common stock (in shares)   (181,000)      
Repurchase and retirement of common stock (2,698)   (2,698)    
Common stock warrant expense 2,598   2,598    
Conversion of redeemable convertible preferred stock upon initial public offering (in shares)   76,287,000      
Conversion of redeemable convertible preferred stock upon initial public offering 81,458 $ 76 81,382    
Issuance of common stock upon initial public offering, net of offering costs (in shares)   22,506,000      
Issuance of common stock upon initial public offering, net of offering costs 548,452 $ 22 548,430    
Issuance of common stock in connection with the employee stock purchase plan (in shares)   29,000      
Issuance of common stock in connection with the employee stock purchase plan 1,395   1,395    
Other comprehensive income (loss) (15,273)     (15,273)  
Net income 154,783       154,783
Ending balance (in shares) at Mar. 31, 2022   192,398,000      
Ending balance at Mar. 31, 2022 $ 878,594 $ 192 702,589 (15,294) 191,107
Ending balance (in shares) at Mar. 31, 2023 0        
Ending balance at Mar. 31, 2023 $ 0        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 43,343   43,343    
Exercise of stock options and common stock warrants (in shares)   3,842,000      
Exercise of stock options and common stock warrants $ 9,929 $ 4 9,925    
Exercise of stock options (in shares) 3,717,000        
Vesting of restricted stock units (in shares)   223,000      
Tax withholding on shares under stock-based compensation awards $ (3,822)   (3,822)    
Repurchase and retirement of common stock (in shares)   (2,675,000)      
Repurchase and retirement of common stock (86,072) $ (2)     (86,070)
Common stock warrant expense 5,356   5,356    
Issuance of common stock in connection with the employee stock purchase plan (in shares)   153,000      
Issuance of common stock in connection with the employee stock purchase plan 4,759   4,759    
Other comprehensive income (loss) 1,211     1,211  
Net income 112,818       112,818
Ending balance (in shares) at Mar. 31, 2023   193,941,000      
Ending balance at Mar. 31, 2023 $ 966,116 $ 194 $ 762,150 $ (14,083) $ 217,855